Enzolytics (ENZC) Stock Statistics & Valuation Metrics

Enzolytics has a market cap or net worth of ―. The enterprise value is ―.

Enzolytics has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

Enzolytics’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.31%.

The current PE Ratio of Enzolytics is ―. Enzolytics’s PEG ratio is 0.05.

In the last 12 months, Enzolytics had revenue of 0.00 and earned -394.00K in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was 115.77M and capital expenditures 4.00, giving a free cash flow of 115.77M billion.

Enzolytics pays an annual dividend of ―, resulting in a dividend yield of ―

Enzolytics upcoming earnings date is ―, ―.

Enzolytics as a current ratio of 0.63, with Debt / Equity ratio of -0.84%

In the past 12 months, Enzolytics has paid 0.00 in taxes.

Enzolytics EV to EBITDA ratio is -6.64, with an EV/FCF ratio of -3.95.

Enzolytics has $200.00M in cash and marketable securities with $996.34K in debt, giving a net cash position of $199.00M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Enzolytics is ―, which is 11.43% higher than the current price. The consensus rating is ―